Adamis Pharmaceuticals stock appears to show signs of accumulation by large players into a consolidation pattern called a Symmetrical Triangle. Shares of Adamis Pharmaceuticals Corporation ADMP soared more than 50% back on June 15th and 16th after the FDA approved the company’s Epinephrine injection. This will be a lost cost alternative to the EpiPen. I first purchased this back on June 15th, got stopped out for a loss, and now I’m taking another run at it with a purchase of ADMP on June 30, 2017.
Adamis Pharmaceuticals Stock Chart
Rising large players volume shows accumulation into the apex of the Symmetrical Triangle pattern.
Latest posts by Lance Jepsen
- YUM Brands Stock Retracement To Previous Resistance Setup - November 20, 2017
- Sarepta Therapeutics In Strong Uptrend From Exondys 51 - November 19, 2017
- Top 16 Companies With Earnings and Revenue Beats - November 19, 2017